Jim Jones Deputy Commissioner for Human Foods of FDA | Official Website
Jim Jones Deputy Commissioner for Human Foods of FDA | Official Website
This is a 45.5% decrease from the number of companies inspected in the previous quarter, when 11 companies received 11 inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics sector. Both the Drugs and Biologics sectors sectors tied for second most common type.
All of the companies were in line with FDA regulations, and don't need to adjust their managing operations or regulatory/administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Burris Philadelphia | Food and Cosmetics | 01/17/2024 | No Action Indicated (NAI) |
| Clario | Drugs | 03/21/2024 | No Action Indicated (NAI) |
| PakSafe Industries | Food and Cosmetics | 01/11/2024 | No Action Indicated (NAI) |
| Transfusion Medicine Department Temple University Hospital | Biologics | 02/23/2024 | No Action Indicated (NAI) |
| United Airlines | Food and Cosmetics | 03/26/2024 | No Action Indicated (NAI) |
| Zentis North America, LLC | Food and Cosmetics | 01/12/2024 | No Action Indicated (NAI) |
Alerts Sign-up